New pain drug SBS-1000 takes first step in human safety trial
Knowledge-focused
Completed
This study tested a single dose of a new experimental drug called SBS-1000 in 48 healthy adults. The main goal was to check for side effects and see how the drug moves through the body. This is an early safety study, so it does not test if the drug actually relieves pain.
Phase: PHASE1 • Sponsor: Sparian Biosciences, Inc • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC